PE Spain Granted Two Projects from Covid-19 Vaccine CMO
The PharmEng Spain team is proud to announce that as of May 27, 2021, we have been granted two new projects from a pan-European pharmaceutical company, specializing and engaging in the research, development, contract manufacturing and marketing of small molecules and biological specialties. This company is also famously one of the main CMO’s for the COVID-19 global vaccine suppliers.
The first project is Granada API Line, where our consultants will be responsible for the comapny’s Vaccine Tech Transfer, Project Management, Process Validation (in PQ, PPQ, report), troubleshooting, protocol adjustment, and QA support.
Along with this, PE Spain will also be responsible for a Verification/Validation Project encompassing IQ, OQ, PQ, and report. Involved in this will be Vial Fill Lines, and more.
PharmEng Spain is looking forward to becoming more involved in the European market through these mentioned projects and subsequent ones ahead.